Compare epidemiology, clinical manifestations and outcome of tuberculosis between diabetic and non-diabetic patients admitted to King Abdulaziz University Hospital in Jeddah, Saudi Arabia. Methods Review the medical data of adult inpatients with tuberculosis from January 2002 to December 2007. Demographic data, location of tuberculosis, sputum positivity for acid fast bacilli, duration of hospitalization and outcome (relapses, drug resistance and inhospital mortality) were compared between the two groups. Results From total of 216 tuberculosis cases, 35 (16%) had diabetes. These were older in age. 68% diabetics were over 50 years compared to 16% non-diabetics. (p=O.OOOl). Ratio of Saudis to non-Saudis with tuberculosis was greater in diabetics than in non-diabetics (p=0.003). Pulmonary tuberculosis was the most common site affected and was associated with poor glycemic control (p = 0.013). Smear positivity for acid fast bacilli was not different in diabetics and non-diabetics (p = 0.66). Outcome was favorable and not significantly different in diabetic patients (p = 0.096) Conclusion Saudi diabetic patients have increased risk of tuberculosis. Pulmonary tuberculosis is most common in diabetics and is associated with poor glucose control. Diabetes does not alter the outcome of tuberculosis significantly.
Introduction
T u berculosis remains a major global public health problem with a high morbidity and mortality. Annually 8-10 million new cases and 3 million deaths are reported 1. A strong association between diabetes mellitus (DM) and tuberculosis (TB) is well documented 2. Both these diseases are major health problems in the Kingdom of Saudi Arabia, where TB is considered an endemic disease 3 and the prevalence of DM is growing rapidly. 4 There is very little data on TB in DM patients in Saudi Arabia. We conducted this study to compare the epidemiology and clinical aspects of TB between diabetic and non-diabetic patients admitted to King Abdulaziz University Hospital (KAUH) in Jeddah, Saudi Arabia.
Materials and Methods
This retrospective study was conducted in KAUH, Jeddah, which is a tertiary hospital in the Western region of Saudi Arabia. Approval of the ethical committee in KAUH was taken. The medical records were reviewed for data collection. Information about demographic data, location of TB, sputum positivity for acid fast bacilli (AFB) staining in case of pulmonary TB (PTB), presence or absence of DM, blood glucose level on admission and 2 months before, duration of hospital stay, number of relapses, resistance to antituberculosis treatment and inhospital mortality, were recorded. Inclusion criteria included adult patients aged 13 years and above who were admitted during the period of January 
Results
As shown in Table I 2, smear positivity for AFB in PTB was 40% (36/90) and was higher in diabetics than non-diabetics 42% (8/19) vs. 37% (26/71), but did not reach statistical significance (p=0.6) As shown in Table 3 there was no significant difference between both groups regarding the duration of hospital stay (27±18 days, range 7-75) in TB patients, (30 ± 18 days, range 10-80) in TB DM patients, with p= 0.138. Readmission for TB occurred in 11/216 (5%) patients. Nine had one recurrence (6 of whom had PTB and 2 were diabetics), two had 2 recurrences (both had PTB and one was diabetic).
Multi drug resistance to TB treatment (MDR-TB) developed in 4/216 (2%) patients. All had PTB and only one was diabetic. All improved on second line antituberculosis therapy.
In-hospital mortality was 3.7% (8/216). All had PTB and although 9% (3/35) were diabetic and 3% (5/181) were non-diabetic, the p-value was not significant (0.096). Most of the diabetics had high blood glucose on admission to the hospital, 26/35 (75%). It was found that these patients had more PTB than patients with controlled blood sugar and it was of significant statistical value (p=0.013) as shown in Table 4 . As shown in Table 5 there was no statistical significant difference between controlled and uncontrolled diabetics regarding AFB positivity (p=0.178). Table 6 shows the duration of hospital stay which was not different between the 2 groups, (p=0.55). It also shows that all the 3 diabetics who had relapses were uncontrolled still the result was not significant statistically (p=0.61). MDR -TB occurred in only 1 diabetic who had uncontrolled blood glucose and the result was not significant (p=0.58) Inhospital mortality occurred in 3 diabetics, 2 had controlled blood glucose but it was in significant (p=O.65)
Discussion
From the total number of TB patients who were studied, 16% had coexisting DM. This 150 figure is similar to other reported cases from Turkey, Malaysia, Indonesia and India. [6] [7] [8] [9] In Saudi Arabia, it was found that the prevalence of DM in Saudi population is 23.7%, as reported by Al Nozha et al in 2004 4 • In our study DM was found in 27% of our Saudi patients. This figure is higher than the one reported by the above-mentioned study, meaning that the prevalence of DM was found to be more in TB patients in our study. The current study showed few differences in some aspects between DM and non DM patients who had TB (including PTB). It showed that as the age increased, more TB was found in DM patients, a similar finding reported by others. 7,10, [11] [12] [13] Moreover it demonstrated that the percentage of TB in Saudi diabetics was significantly higher than that in Saudis without DM (51% vs 26%). This finding is similar to another study from Saudi Arabia. 11 It also showed that the percentage of male diabetic patients was slightly higher in comparison to non-diabetic males, which is supported also by previous studies. 7, 11, 12 The above findings showed statistical significance and it is alarming to know that Saudi diabetics are having higher prevalence of TB than non-Saudis and nondiabetic Saudis which shows the positive association between DM and TB in Saudi Arabia.
In the present study, PTB was considered the most common form found in DM patients, whereas in non-diabetics extrapulmonary TB was more common. The increased association of DM with PTB rather than extrapulmonary TB was also reported previously 7, indicating that the presence of DM continues to play an important role in the development of PTB. In extrapulmonary TB, bone disease was the most common form found in DM patients, whereas lymph node involvement was the predominant site in non-diabetic patients, as was the case in another report? The high rate of involvement of lymph nodes in extrapulmonary TB in our total TB patients in comparison to other sites was also seen in other studies. 14, 15 Several studies reported strong association between DM and smear positive PTB 9, 13, 16 but that was not seen in our study as the difference was not great to be of statistical significance although lh of DM patients were positive for AFB compared to about 1/3 of non-diabetic patients. This finding was similar to findings in other studies. 6, 17 Although there is evidence that DM patients with TB have worse TB outcome than those without DM, 16, 18 this was not shown in the number of relapses in our study, which had no relation to the presence of DM, and it was consistent with other reports. 7 MDR-TB was 4% in our study, that was lower than that reported previously in Jeddah (5.1% and 20.7%) 19, 20 and there was no relation between the presence of DM and MDR-TB. A finding that was consistent with previous reports 6,7 and one from Saudi Arabia.'! Inhospital mortality showed a difference between diabetics and non diabetics (9% vs 3%) in our study but the statistical value was not significant, probably because the number of mortalities was small and hindered reaching to significant conclusions. Most of the DM patients had uncontrolled blood glucose levels and had significantly more PTB than those with controlled blood glucose. The reason probably is the adverse effect of PTB on glycemic control that improves with antituberculosis treatment.st Another explanation is that poorly controlled glucose level is usually considered to be the main factor causing increased susceptibility to infections. 22 It is well known that DM is associated with an increased risk of TB with an overall increased risk around 1.5 to 8 times higher than the normal population." This is why both these diseases are considered to be bad companions. In our study, high blood glucose had no relation to smear positivity for AFB, to duration of hospital stay nor to the outcome of these patients. Probably a bigger number of patients may have yielded a positive result than shown here. We conclude that Saudi diabetic patients are more affected with TB, but there is no difference in the outcome between diabetic and non-diabetic patients with TB. Since both diseases are highly prevalent in our community and influence each other, we recommend that more strict measure to be carried out to combat the spread of TB and tightly control DM. Active case finding is recommended by performing chest x-rays routinely for all diabetic patients at diagnosis and whenever they develop unexplained deterioration of health. Latent PTB cases should be offered chemoprophylaxis. We also recommend to consider having combined clinics for both diseases for better follow up of patients. It would be interesting to do a prospective study in diabetic patients with TB in different regions of Saudi Arabia to see the trend of clinical presentations and outcome and would be better to include larger number of patients than our current study to reach to more significant results. 
